References
Weenig RH. Pathogenesis of calciphylaxis: Hans Selye to nuclear factor k-B. J Am Acad Dermatol. 2008; 58: 458–471.
Nigwekar SU, Wolf M, Sterns RH, et al. Calciphylaxis from Nonuremic Causes: A Systematic Review. Clin J Am Soc Nephrol 2008; 3: 1139–1143.
Fine A, Zacharias J. Calciphylaxis is usually non-ulcerating: risk factors, outcome and therapy. Kidney Int 2002; 61: 2210–2217.
Ahmed S, O’Neil KD, Hood AF. Calciphylaxis is associated with hyperphosphatemia and increased osteopontin expression by vascular smooth muscle cells. Am J Kidney Dis 2001; 37: 1267–1276.
Weenig RH, Sewell LD, Davis MD, et al. Calciphylaxis: natural history, risk factor analysis, and outcome. J Am Acad Dermatol 2007; 56: 569–579.
Hafner J, Kuesh G, Wahl C, et al. Uremic small-small artery disease with medial calcification and intimal hyperplasia (so-called calciphylaxis): a complication of chronic renal failure and benefit from parathyroidectomy. J Am Acad Dermatol 1995; 33: 954–962.
Galimberti RL, Farias Edos R, Parra IH, et al. Cutaneous necrosis by calcific uremic arteriolopathy. Int J Dermatol 2005; 44: 101–106.
Wilmer WA, Magro CM. Calciphylaxis: emerging concepts in prevention, diagnosis, and treatment. Semin Dial 2002; 15: 172–186.
Lal G, Nowell AG, Liao J, et al. Determinants of survival in patients with calciphylaxis: a multivariate analysis. Surgery 2009; 149: 1028–1034.
Vedvyas C, Winterfield LS, Vleugels RA. Calciphylaxis: A systematic review of existing and emerging therapies. J Am Acad Dermatol 2011; 67: 253–260.
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Veitch, D., Wijesuriya, N., McGregor, J.M. et al. Clinicopathological features and treatment of uremic calciphylaxis: a case series. Eur J Dermatol 24, 113–115 (2014). https://doi.org/10.1684/ejd.2013.2231
Published:
Issue Date:
DOI: https://doi.org/10.1684/ejd.2013.2231